Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Digital long-term follow-up for heart disease survivors using HeartCheck

Official title: Digital Long-term Follow-up of Patients With Coronary Artery Disease: a Randomized Controlled Trial

Run by Oslo University Hospital · NCT07720349 · Data updated 2026-11-12

A smartphone-based program called HeartCheck is tested to help adults who survived a recent heart attack or PCI stay on top of risk factors and medications over time.

More Coronary Artery Disease trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment630 (estimated)
SponsorOslo University Hospital
Academic / other
Locations2 sites (Arendal and 1 other locations)
StatusRecruiting
StartedApril 1, 2026
Main results expectedDecember 31, 2028
Study endsDecember 2029
Registry record updatedJuly 31, 2026
Trial IDNCT07720349 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 who recently survived an AMI or PCI and own a smartphone or tablet are ideal candidates.

Probably not a fit

Patients without access to a compatible device or who have language barriers may be less likely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests a digital follow-up solution (HeartCheck) designed to support secondary prevention after an acute myocardial infarction (AMI). Eligible adults with recent AMI or PCI and access to a smartphone participate in a randomized design to see if education, reminders, and clear goal-setting improve risk-factor control and drug adherence during long-term care. The program aims to increase awareness of lifestyle factors and cardiovascular risk and to provide guidance for medication adherence. The study is conducted at Oslo University Hospital and Sorlandet Hospital, with the primary outcome focusing on risk-factor management and adherence, compared with standard care. No phase information is provided.

Why it matters

Potential benefit: If successful, HeartCheck could help patients better manage their risk factors and stay adherent to prescribed therapies after a heart attack.

How similar studies have gone: Digital tools for secondary prevention have shown promise in improving adherence and risk-factor control in some prior studies, but results vary by setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* \>18 years of age
* survived a recent (\<30 days) AMI and/or PCI
* access to a smartphone or tablet
* signed written informed consent

Exclusion Criteria:

* patient does not understand Norwegian
* patient is unable to comply with the study procedures due to severe comorbidities or high age

Where it's running

  • Sørlandet Hospital Arendal
    Arendal, Norway
    Recruiting
  • Oslo University Hospital Ullevål
    Oslo, Norway
    Recruiting

Study contacts

  • Principal investigator: Sigrun Halvorsen — Oslo University Hospital
  • Study coordinator: Sigrun Halvorsen
  • Email: sigruha@uio.no
  • Phone: +4722119101

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.